000597 东北制药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.0947.5098.0492.4380.310
总资产报酬率 ROA (%)1.3972.4652.5950.7810.099
投入资产回报率 ROIC (%)1.7943.3053.5701.0510.138

边际利润分析
销售毛利率 (%)34.53340.67638.95539.48639.160
营业利润率 (%)5.4846.0447.9052.3002.074
息税前利润/营业总收入 (%)5.5895.5596.0552.8902.685
净利润/营业总收入 (%)3.5884.5614.0541.1720.147

收益指标分析
经营活动净收益/利润总额(%)100.377118.58471.086145.325158.427
价值变动净收益/利润总额(%)0.9871.7630.00045.2090.000
营业外收支净额/利润总额(%)3.631-2.059-32.528-55.913-66.761

偿债能力分析
流动比率 (X)1.0701.0220.9420.8290.759
速动比率 (X)0.9250.8800.7970.6770.588
资产负债率 (%)63.07466.22565.87167.44766.116
带息债务/全部投入资本 (%)50.98754.84748.86452.969--
股东权益/带息债务 (%)90.02176.26595.51579.39088.722
股东权益/负债合计 (%)56.54949.31650.11946.61549.489
利息保障倍数 (X)-54.957-15.28767.4122.0431.863

营运能力分析
应收账款周转天数 (天)86.29282.73478.06978.6890.000
存货周转天数 (天)88.65695.13182.60291.3160.000